September 25, 2009 at 06:00 AM EDT
BIOLASE and Levin Group to Collaborate on Success Program; Announce World Clinical Laser Institute Symposium
Levin to Present Program at Symposium

IRVINE, CA -- (Marketwire) -- 09/25/09 -- BIOLASE Technology, Inc. (NASDAQ: BLTI) today announced that it has engaged Baltimore-based Levin Group, Inc., a leading international dental practice consulting firm, to develop a practice management system for the successful integration and implementation of BIOLASE dental lasers into everyday dental offices. The practice management system will showcase the value of BIOLASE lasers as an effective technology that has been allowing dental practices to increase the number of services they provide and enhance the patient experience. This new program will help current and future BIOLASE users integrate lasers more seamlessly into the practice as a standard tool to be used in everyday dentistry. This program will be designed to teach the dentist and dental team how to maximize the use of their laser and achieve an even higher positive return-on-investment.

Dr. Roger Levin will present the practice integration program at the World Clinical Laser Institute (WCLI) dentistry symposium scheduled for March 4-6, 2010, at the Marriott San Diego Hotel and Marina in San Diego, CA. The concurrently announced event is co-sponsored by BIOLASE and Henry Schein, Inc. (NASDAQ: HSIC), the exclusive distributor of BIOLASE products in North America and many countries around the world. The WCLI Super Symposium will cover general laser procedures, endodontic techniques, surgery, and periodontal applications, as well as a review of the latest dental technologies on the market, providing an in-depth understanding of the role that lasers play in today's successful dental practice.

BIOLASE Chief Executive Officer David M. Mulder said, "Our Company has done an effective job of attracting and nurturing relationships with the most progressive and innovative dental practitioners, educators, distributors and other professionals worldwide. We are also pleased to have attracted global business partners like Henry Schein and Procter & Gamble (P&G). As we now drive adoption across the broader dental markets, it is critical that we achieve our goal of educating the entire dental community on the significant difference that BIOLASE technologies can bring to the practices and the lives of every dentist. It is also critical to ensure that doctors and their staffs feel confident and secure integrating lasers into their practices. We believe the program we are collaborating on with the Levin Group will help us achieve our goals."

Mulder continued, "Educating dentists on the clinical and economic benefits of incorporating dental laser systems is an important part of our joint mandate with Henry Schein and we believe this venue allows us to accomplish that in an effective and efficient manner. I am confident that the Levin Group's participation will be a highlight of this year's WCLI program."

Attendance at this event is limited to dentists, hygienists and office staff only. For more information, email info@wcli.org.

About the World Clinical Laser Institute

For over a decade, the World Clinical Laser Institute, the world's largest laser dentistry education organization, has been dedicated to advancing knowledge and training in laser dentistry. Through more than one hundred symposiums held in locations across the globe, thousands of dentists have developed their practice and enhanced their expertise in laser dentistry. A truly global organization, the WCLI includes dentists from New York and London to Sydney and Seoul. For more information, go to http://www.learnlasers.com/.

About Levin Group, Inc.

Levin Group (www.levingroup.com), the leading international consulting firm for dentists, specialists and dental corporations for 24 years, is based in Owings Mills, MD, with a second office in Phoenix, AZ. Founded by Chairman and CEO, Dr. Roger Levin, Levin Group provides practice management and marketing consulting programs to thousands of doctors every year.

For further information about the Levin Group contact:
Lori Gerstley, Manager of Professional Relations
443-471-3164
lgerstley@levingroup.com

About Henry Schein

Henry Schein, a Fortune 500® company and a member of the NASDAQ 100® Index, is recognized for its excellent customer service and highly competitive prices. The Company's four business groups -- Dental, Medical, International and Technology -- serve more than 575,000 customers worldwide, including dental practitioners and laboratories, physician practices and animal health clinics, as well as government and other institutions. The Company operates through a centralized and automated distribution network, which provides customers in more than 200 countries with a comprehensive selection of more than 90,000 national and Henry Schein private-brand products in stock, as well as more than 100,000 additional products available as special-order items. Henry Schein also provides exclusive, innovative technology offerings for dental, medical and veterinary professionals, including value-added practice management software and electronic health record solutions.

Headquartered in Melville, N.Y., Henry Schein employs over 12,500 people and has operations or affiliates in 23 countries. The Company's net sales reached a record $6.4 billion in 2008. For more information, visit the Henry Schein Web site at www.henryschein.com.

About BIOLASE Technology, Inc.

BIOLASE Technology, Inc. (http://www.biolase.com), the world's leading dental laser company, develops, manufactures and markets Waterlase technology and lasers and related products that advance the practice of dentistry and medicine. The Company's products incorporate patented and patent pending technologies designed to provide clinically superior performance with reduced pain, faster and biological recovery times. BIOLASE's principal products are dental laser systems that perform a broad range of dental procedures, including cosmetic and complex surgical applications. Other products under development address ophthalmology, pain management and other medical and consumer markets.

This press release may contain forward-looking statements within the meaning of safe harbor provided by the Securities Reform Act of 1995 that are based on the current expectations and estimates by our management. These forward-looking statements can be identified through the use of words such as "anticipates," "expects," "intends," "plans," "believes," "seeks," "estimates," "may," "will," and variations of these words or similar expressions. Forward-looking statements are based on management's current, preliminary expectations and are subject to risks, uncertainties and other factors which may cause the Company's actual results to differ materially from the statements contained herein, and are described in the Company's reports it files with the Securities and Exchange Commission, including its annual and quarterly reports. No undue reliance should be placed on forward-looking statements. Such information is subject to change, and we undertake no obligation to update such statements.

For further information, please contact:
Jill Bertotti
Allen & Caron
+1-949-474-4300

Stock Market XML and JSON Data API provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Press Release Service provided by PRConnect.
Stock quotes supplied by Six Financial
Postage Rates Bots go here